Literature DB >> 518593

Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

M L Blank, F Snyder, L W Byers, B Brooks, E E Muirhead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 518593     DOI： 10.1016/0006-291x(79)91163-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  86 in total

Review 1.  Lipid acetylation reactions and the metabolism of platelet-activating factor.

Authors:  R R Baker
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

2.  The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.

Authors:  M B Bastos da Silva; P Gustin; F Herion; R Raskinet; J L David; T Gougnard; G Plomteux; D Desmecht; P Lekeux
Journal:  Vet Res Commun       Date:  1997-10       Impact factor: 2.459

3.  Lyso platelet activating factor (LysoPAF) and its enantiomer. Total synthesis and carbon-13 NMR spectroscopy.

Authors:  M P Murari; R Murari; S Parthasarathy; C A Guy; V V Kumar; B Malewicz; W J Baumann
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

4.  Regulation of the biosynthesis of platelet-activating factor in alveolar macrophages.

Authors:  T Sugiura; A Ojima-Uchiyama; Y Masuzawa; M Fujita; Y Nakagawa; K Waku
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.

Authors:  T Mikami; K Fukushi; M Ishitani; K Ishitani; S Suzuki; M Suzuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.

Authors:  R Korth; M Hirafuji; C L Keraly; D Delautier; J Bidault; J Benveniste
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.

Authors:  M C Garcia; C Garcia; M A Gijon; S Fernandez-Gallardo; F Mollinedo; M Sanchez Crespo
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Predominant expression of platelet-activating factor receptor in the rat brain microglia.

Authors:  M Mori; M Aihara; K Kume; M Hamanoue; S Kohsaka; T Shimizu
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.